Key result
The high-density mesh ablation catheter achieved complete pulmonary vein isolation in 45% of patients as a stand-alone tool, with 64% of patients free of symptomatic AF at 1 year.
Why the study?
Does the high-density mesh ablation catheter effectively map and isolate pulmonary veins in patients with recurrent atrial fibrillation?
Does the high-density mesh ablation catheter effectively map and isolate pulmonary veins in patients with recurrent atrial fibrillation?
The high-density mesh ablation catheter is a reliable mapping tool for pulmonary vein isolation, though catheter design modifications are needed to reduce the need for touch-up ablations.
May support mesh catheter as PV mapping adjunct; leaves open stand-alone PVI efficacy in recurrent AF.
BACKGROUND: Pulmonary vein isolation (PVI) is usually performed with multiple point-by-point radiofrequency ablation with a second multielectrode circular mapping catheter to validate isolation. We evaluated a 30-mm high-density mesh electrode (HDMA) for mapping and PVI in patients with recurrent atrial fibrillation (AF). METHODS: In 13 patients (validation group) up to three pulmonary veins (PVs) were targeted with the HDMA. A circular mapping catheter was used to validate PVI. PVI was completed with a CARTO-guided approach (Biosense Webster, Diamond Bar, CA, USA) followed by a voltage remap. In 11 patients (feasibility group) the HDMA catheter was evaluated as a stand-alone mapping and ablation tool. RESULTS: The diagnostic accuracy of the HDMA catheter to evaluate PVI was 100%. The encircled low-voltage area (<0.15 mV) after HDMA-guided PVI was smaller compared to CARTO-guided PVI. In the feasibility group 76% of the PVs could be isolated. Complete isolation of all PVs was feasible in five patients (45%) with a mean procedure and fluoroscopy time of respectively 180 +/- 39 minutes and 40 +/- 14 minutes. After 1 year 64% of the patients were free of symptomatic AF. CONCLUSIONS: The HDMA electrode is a reliable mapping tool to validate PVI. The majority of PVs can be isolated, but on a patient basis touch-up ablations are necessary in more than 50% of the cases. Therefore, modifications in catheter design are required. The small area of voltage abatement points to an ostial left atrium-pulmonary vein disconnection. Initial clinical results in a small number of patients are promising.
No takes yet. Share an insight, caveat, or question.
Greef et al. (2009) studied recurrent atrial fibrillation (AF) (n=24). 30-mm high-density mesh electrode (HDMA) catheter vs. CARTO-guided approach was evaluated on Freedom from symptomatic AF at 1 year. The high-density mesh ablation catheter achieved complete pulmonary vein isolation in 45% of patients as a stand-alone tool, with 64% of patients free of symptomatic AF at 1 year.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: